Discovery of novel phosphatidylcholine-specific phospholipase C drug-like inhibitors as potential anticancer agents.

[1]  J. Reynisson,et al.  The Development of a Weighted Index to Optimise Compound Libraries for High Throughput Screening , 2018, Molecular informatics.

[2]  M. Takemoto,et al.  A novel role of the antitumor agent tricyclodecan‐9‐yl‐xanthogenate as an open channel blocker of KCNQ1/KCNE1 , 2018, European journal of pharmacology.

[3]  J. Reynisson,et al.  Virtual screening and biophysical studies lead to HSP90 inhibitors. , 2017, Bioorganic & medicinal chemistry letters.

[4]  O. Lavrik,et al.  New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties. , 2016, Bioorganic & medicinal chemistry.

[5]  M. E. Castelli,et al.  High-level production of Bacillus cereus phospholipase C in Corynebacterium glutamicum. , 2015, Journal of biotechnology.

[6]  M. Brimble,et al.  Virtual screening for novel Atg5–Atg16 complex inhibitors for autophagy modulation , 2015 .

[7]  Tian Zhu,et al.  Hit identification and optimization in virtual screening: practical recommendations based on a critical literature analysis. , 2013, Journal of medicinal chemistry.

[8]  D. Hwang,et al.  Phospholipase signalling networks in cancer , 2012, Nature Reviews Cancer.

[9]  Andreas Bender,et al.  Recognizing Pitfalls in Virtual Screening: A Critical Review , 2012, J. Chem. Inf. Model..

[10]  R. M. Adibhatla,et al.  Tricyclodecan-9-yl-Xanthogenate (D609) Mechanism of Actions: A Mini-Review of Literature , 2012, Neurochemical Research.

[11]  A. Molinari,et al.  Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells , 2012, Breast Cancer Research.

[12]  Yunde Zhao.  Auxin biosynthesis: a simple two-step pathway converts tryptophan to indole-3-acetic acid in plants. , 2012, Molecular plant.

[13]  Patricia González‐Bulnes,et al.  2-aminohydroxamic acid derivatives as inhibitors of Bacillus cereus phosphatidylcholine preferred phospholipase C PC-PLC(Bc). , 2010, Bioorganic & medicinal chemistry.

[14]  Dong-Seok Kim,et al.  UVB-activated indole-3-acetic acid induces apoptosis of PC-3 prostate cancer cells. , 2010, Anticancer research.

[15]  Yun Zhang,et al.  Targeting phosphatidylcholine-specific phospholipase C for atherogenesis therapy. , 2010, Trends in cardiovascular medicine.

[16]  M. Pisanu,et al.  Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells , 2010, Breast Cancer Research.

[17]  P. Workman,et al.  The identification of novel PLC-gamma inhibitors using virtual high throughput screening. , 2009, Bioorganic & medicinal chemistry.

[18]  Thomas Stützle,et al.  Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS , 2009, J. Chem. Inf. Model..

[19]  C. Carson,et al.  Tadalafil in the treatment of erectile dysfunction , 2008, Therapeutics and clinical risk management.

[20]  D. Gupta,et al.  Virtual high throughput screening (vHTS) - A perspective , 2008, Bioinformation.

[21]  S. Canevari,et al.  Phosphatidylcholine-specific phospholipase C activation in epithelial ovarian cancer cells. , 2008, Cancer research.

[22]  N. Goodey,et al.  Structural studies examining the substrate specificity profiles of PC-PLC(Bc) protein variants. , 2006, Archives of biochemistry and biophysics.

[23]  Kyoung-Chan Park,et al.  Hydrogen peroxide is a mediator of indole‐3‐acetic acid/horseradish peroxidase‐induced apoptosis , 2006, FEBS letters.

[24]  Marcel L Verdonk,et al.  General and targeted statistical potentials for protein–ligand interactions , 2005, Proteins.

[25]  D. Frank Hsu,et al.  Consensus Scoring Criteria for Improving Enrichment in Virtual Screening , 2005, J. Chem. Inf. Model..

[26]  Richard D. Taylor,et al.  Improved protein–ligand docking using GOLD , 2003, Proteins.

[27]  P. Wardman.  Indole-3-acetic acids and horseradish peroxidase: a new prodrug/enzyme combination for targeted cancer therapy. , 2002, Current pharmaceutical design.

[28]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[29]  Shaomeng Wang,et al.  How Does Consensus Scoring Work for Virtual Library Screening? An Idealized Computer Experiment , 2001, J. Chem. Inf. Comput. Sci..

[30]  J. Jaffrezou,et al.  Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and nuclear factor kappaB activation in tumour-necrosis-factor-alpha-treated immature acute-myeloid-leukaemia cells. , 2000, The Biochemical journal.

[31]  P. Hergenrother,et al.  A novel class of zinc-binding inhibitors for the phosphatidylcholine-preferring phospholipase C from Bacillus cereus. , 2000, The Journal of organic chemistry.

[32]  P. Hergenrother,et al.  Catalytic cycle of the phosphatidylcholine-preferring phospholipase C from Bacillus cereus. Solvent viscosity, deuterium isotope effects, and proton inventory studies. , 1999, Biochemistry.

[33]  G. V. Paolini,et al.  Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes , 1997, J. Comput. Aided Mol. Des..

[34]  M. Roberts,et al.  Cloning, overexpression, refolding, and purification of the nonspecific phospholipase C from Bacillus cereus. , 1997, Protein expression and purification.

[35]  Huili Chen,et al.  CHANGES OF PHOSPHATIDYLCHOLINE‐SPECIFIC PHOSPHOLIPASE C IN HEPATOCARCINOGENESIS AND IN THE PROLIFERATION AND DIFFERENTIATION OF RAT LIVER CANCER CELLS , 1997, Cell biology international.

[36]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[37]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[38]  S. Martin,et al.  Design, Synthesis, and Evaluation of Phospholipid Analogs as Inhibitors of the Bacterial Phospholipase C from Bacillus cereus , 1994 .

[39]  Marina Lasagni,et al.  New molecular descriptors for 2D and 3D structures. Theory , 1994 .

[40]  Edward Hough,et al.  High-resolution (1.5 Å) crystal structure of phospholipase C from Bacillus cereus , 1989, Nature.

[41]  C. Little,et al.  Increased arachidonic acid metabolites from cells in culture after treatment with the phosphatidylcholine-hydrolyzing phospholipase C from Bacillus cereus. , 1987, Prostaglandins.

[42]  J. Bomalaski,et al.  Antibodies prepared to Bacillus cereus phospholipase C crossreact with a phosphatidylcholine preferring phospholipase C in mammalian cells. , 1986, Biochemical and biophysical research communications.

[43]  C. Little,et al.  Inhibition of Bacillus cereus phospholipase C by univalent anions. , 1982, The Biochemical journal.

[44]  C. Vines.  Phospholipase C. , 2012, Advances in experimental medicine and biology.

[45]  Tudor I. Oprea,et al.  Compound collection preparation for virtual screening. , 2012, Methods in molecular biology.

[46]  G. Oliva,et al.  Virtual screening and its integration with modern drug design technologies. , 2008, Current medicinal chemistry.

[47]  Kyoung-Chan Park,et al.  Oxidation of indole-3-acetic acid by horseradish peroxidase induces apoptosis in G361 human melanoma cells. , 2004, Cellular signalling.

[48]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[49]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[50]  E. Amtmann.  The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C. , 1996, Drugs under experimental and clinical research.